-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $350 Price Target

Benzinga·11/17/2026 12:11:32
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates Revolution Medicines (NASDAQ:RVMD) with a Buy and maintains $350 price target.